NCT00788463View on ClinicalTrials.gov

A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 23, 2006

Primary Completion Date

March 30, 2009

Study Completion Date

November 30, 2011

Conditions
Nasal Polyps
Interventions
DRUG

Intranasal Beclomethasone aerosol

Beclomethasone aerosol intranasal, 100ug each nostril, twice daily for 6 months.

DRUG

Intranasal Beclomethasone spray

Beclomethasone spray intranasal, 100ug each nostril, twice daily for 6 months.

Trial Locations (1)

N6A 4G5

Allergy Clinic, London Health Sciences Centre, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT00788463 - A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps | Biotech Hunter | Biotech Hunter